Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Insider Buying - again

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Oct 08, 2021 2:48pm

152 Views

Post# 33989928

RE:Insider Buying - again

Can't he fill out a report correctly? Where the hell is the buy price?

Pareto8020 wrote: Howard just bought another 10,000 shares in the open market. He's up to over 8M shares now.

https://www.canadianinsider.com/ca-filing-details/3815781

I guess after the hollow "update" didn't do anything he decided to go back and try the old tested and true buying shares in the public market with the rest of us lowly peeps.

Or perhaps it is his signal that a massive new contract is on the horizon and the watershed moment for SBM is nearly here.

I pray for the later but been burnt so many times not going to get my hopes up.

Filing
Date Transaction
Date Insider Name Ownership
Type Securities Nature of transaction Volume or Value Price

Oct 7/21 Oct 5/21 Verrico, Howard Jarman Direct Ownership Common Shares 10 - Acquisition in the public market 10,000